Detalles de la búsqueda
1.
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies.
Semin Cancer Biol
; 91: 27-34, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871633
2.
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.
Blood
; 140(5): 419-437, 2022 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34758074
3.
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel.
Hematol Oncol
; 42(1): e3215, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37649350
4.
Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study.
Br J Dermatol
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596857
5.
Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
Br J Dermatol
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38595050
6.
Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai-Dorfman disease in distinct lesions: A unique association.
J Cutan Pathol
; 51(1): 7-10, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636954
7.
Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas: Insights from a Real-Life Experience.
Dermatology
; 240(2): 329-336, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38008073
8.
Safety of omalizumab in chronic urticaria during pregnancy: a real-life study.
Clin Exp Dermatol
; 49(4): 344-347, 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37956096
9.
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.
J Eur Acad Dermatol Venereol
; 2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456518
10.
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study.
J Eur Acad Dermatol Venereol
; 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38284131
11.
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment.
J Dtsch Dermatol Ges
; 22(1): 34-42, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37926830
12.
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma.
Br J Surg
; 110(7): 818-830, 2023 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37131298
13.
Long-term psychological outcome of patients with moderate-to-severe atopic dermatitis continuously treated with Dupilumab: Data up to 3 years.
Exp Dermatol
; 32(6): 852-858, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36856013
14.
The Limitation of Accessing Hospital Services Due to COVID-19 Pandemic: A Pilot Study of the Telephone Triage to Re-Organize the Access to a Center for Sexual Health in Northwest Italy.
Sex Transm Dis
; 50(9): 603-606, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728659
15.
First pilot case-control interventional study using autologous extracellular vesicles to treat chronic venous ulcers unresponsive to conventional treatments.
Pharmacol Res
; 190: 106718, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36878306
16.
Follicular colonization in melanocytic nevi and melanoma: A literature review.
J Cutan Pathol
; 50(8): 773-778, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36820529
17.
Advanced Cutaneous Squamous Cell Carcinoma: Italian Multicentric Retrospective Analysis of Patient Profiles and Therapeutic Approaches.
Dermatology
; 239(3): 422-428, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921583
18.
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness.
Dermatology
; 239(6): 868-876, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37311439
19.
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
J Eur Acad Dermatol Venereol
; 37(10): 1991-1998, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335879
20.
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.
J Eur Acad Dermatol Venereol
; 37(4): 680-688, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36606565